Carbon-14 labeling of Saxagliptin (BMS-477118)-Reference-Cited by-同舟云学术

Carbon-14 labeling of Saxagliptin (BMS-477118)

Published:2007 Issue:13 Volume:50 Page:1224-1229
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J Label Compd Radiopharm

Author:

Cao Kai,Bonacorsi Samuel J.,Balasubramanian Balu,Hanson Ronald L.,Manchand Percy,Godfrey Jollie D.,Fox Rita,Christopher Lisa J.,Su Hong,Iyer Ramaswamy

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology, Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Reference20 articles.

1. Glucagon-like Peptide-1: The Basis of a New Class of Treatment for Type 2 Diabetes

2. Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes

3. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

4. Long-Term Treatment With the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and β-Cell Glucose Responsiveness in VDF (fa/fa) Zucker Rats

5. Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fast Carbon Isotope Exchange of Carboxylic Acids Enabled by Organic Photoredox Catalysis;Journal of the American Chemical Society;2021-01-28

2. Synthesis of Radiolabelled Compounds for Clinical Studies;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2020

3. Oxalyl Chloride: A Versatile Reagent in Organic Transformations;ChemistrySelect;2019-05-31

4. Synthesis of Radiolabelled Compounds for Clinical Studies;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2017

5. The synthesis of14C-labeled,13CD2-labeled saxagliptin, and its13CD2-labeled 5-hydroxy metabolite;Journal of Labelled Compounds and Radiopharmaceuticals;2014-02-12